NovoCure
NVCR
NVCR
200 hedge funds and large institutions have $3.06B invested in NovoCure in 2019 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 66 increasing their positions, 67 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
200
Holders Change
+34
Holders Change %
+20.48%
% of All Funds
4.34%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
48
Increased
66
Reduced
67
Closed
14
Calls
$65.4M
Puts
$11.8M
Net Calls
+$53.5M
Net Calls Change
+$26.7M
Top Buyers
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
$387M |
| 2 |
Capital World Investors
Los Angeles,
California
|
$243M |
| 3 |
Renaissance Technologies
New York
|
$89.4M |
| 4 |
D.E. Shaw & Co
New York
|
$31.6M |
| 5 |
Two Sigma Investments
New York
|
$28.5M |
